Evidence map›Paper›PMID 31183191›Full record

ArticleJournal of gastrointestinal oncology2019

Assessment of the external validity of the AJCC 8

Hani Oweira, Omar Abdel-Rahman, Arianeb Mehrabi, Christoph Reissfelder

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hani OweiraCenter for Visceral and Specialized Tumor Surgery, Hirslanden Medical Center, Zurich, Switzerland.
Omar Abdel-RahmanClinical Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Arianeb MehrabiDepartment of General, Visceral, and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.
Christoph ReissfelderDepartment of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe current study evaluates the validity and performance of the 8

methodsSurveillance, Epidemiology and End Results (SEER) database [2004-2015] was explored and AJCC 6

resultsA total of 2,997 small intestinal adenocarcinoma patients were eligible and included in the analysis. Overall survival was compared according to the three AJCC staging systems. For the three versions, the P value for the trend in overall survival was significant (P<0.0001). Cancer-specific Cox regression hazard was calculated for the three staging systems. Pairwise hazard ratio comparisons between different AJCC 6

conclusionsThere is no evidence that AJCC 8

Indexed as

American Joint Committee on Cancer (AJCC)Prognosissmall intestinal adenocarcinomastagingSurveillance, Epidemiology and End Results (SEER)

Identifiers

PMID31183191
PMCPMC6534713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.